Open Access Repository

Utility of FDG-PET imaging for risk stratification of pancreatic neuroendocrine tumors in MEN1

Kornaczewski Jackson, ER, Pointon, OP, Bohmer, R and Brugess, JR ORCID: 0000-0003-4748-9571 2017 , 'Utility of FDG-PET imaging for risk stratification of pancreatic neuroendocrine tumors in MEN1' , Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 6 , pp. 1926-1933 , doi: 10.1210/jc.2016-3865.

Full text not available from this repository.

Abstract

Context:Patients with multiple endocrine neoplasia type 1 (MEN1) are at high risk of malignant pancreatic neuroendocrine tumors (pNETs). Structural imaging is typically used to screen for pNETs but is suboptimal for stratifying malignant potential.Objective:To determine the utility of fluorodeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) for predicting the malignant potential of pNETs in MEN1.Design:Retrospective observational study.Setting:Tertiary referral hospital.Patients:Forty-nine adult patients with MEN1 carrying a common MEN1 mutation who underwent 18F-FDG PET/CT for MEN1 surveillance between 1 January 2010 and 30 September 2016.Interventions:Structural and functional imaging (magnetic resonance imaging, CT, ultrasonography, and 18F-FDG PET/CT) and surgical histopathology.Main Outcome Measures:pNET size, behavior, and histopathology.

Item Type: Article
Authors/Creators:Kornaczewski Jackson, ER and Pointon, OP and Bohmer, R and Brugess, JR
Keywords: FDG-PET, pancreas, neuroendocrine tumours, MEN 1
Journal or Publication Title: Journal of Clinical Endocrinology and Metabolism
Publisher: Oxford University Press
ISSN: 0021-972X
DOI / ID Number: 10.1210/jc.2016-3865
Copyright Information:

Copyright 2017 Endocrine Society

Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP